In another example of the effect of modifier genes, Schiefermeier et al [45] tried to delineate why some patients have later-onset neurologic as well as hepatic symptoms by examining the potential ...
Presenting Author: Aftab Ala, MBBS, M.D., FRCP, Ph.D. The abstract is currently available on the conference website, and the materials for the oral presentation will be available at www.monopartx.com ...
Treatment reversed tremors, ataxia, anxiety-like behavior, liver and kidney pathology damage, reduced copper accumulation, normalized ALT, AST, and bilirubin levels, and improved survival. Building on ...
MIAMI, FL / ACCESS Newswire / June 11, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company,” a preclinical-stage biotechnology company focused on reversing biological aging and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback